Indian NGOs Worry About Drug Maker M&As
This article was originally published in PharmAsia News
Executive Summary
Non-governmental organizations in India are expressing concern about the future of the country's drug-making industry if there is a spate of mergers and acquisitions. One group representing lawyers suggested public-interest issues should be considered before the government allows any company in a vital area such as medicine to be merged with another, particularly a foreign one. It said the purchase of India's largest pharmaceutical, generics maker Ranbaxy Laboratories, by a Japanese firm could cripple the country's position as a drug-production hub. (Click here for more